Hand radiographs were evaluated for the degree of CMC ... Conclusions: No clinical benefit was gained from intra-articular steroid injection to the CMCJ in moderate to severe osteoarthritis compared ...

The hand search identified one additional article for inclusion, leading to a total of 31 articles finally included (see online supplementary file S6). The additional search on the added value of ...

Delivery of MSCs might be attained by direct intra-articular injection or by graft of engineered constructs derived from cell-seeded scaffolds; this latter approach could provide a three ...

After reading the abstracts, there were 290 possibly relevant articles on adverse effects after extra-articular injection. After studying the full-text articles and references of the included ...

It is a degenerative disease that appears to be caused by both biomechanical and bio-chemical factors. Intra-articular (IA) injection treatment is one of the main treatment methods for OA because of ...

We present a unique case of a man in his 60s with a knee intra-articular loose body causing a compression neuropathy on his common peroneal (fibular) nerve (CPN). This neuropathy caused a reduction in ...

Jan 12 (Reuters) - Drug maker Johnson & Johnson (JNJ.N), opens new tab is exploring a bid to acquire Intra-Cellular Therapies (ITCI.O), opens new tab, a biopharmaceutical company, Bloomberg News ...

Once completed, Intra-Cellular Therapies’ stock will be delisted from the Nasdaq. Johnson & Johnson plans to fund the acquisition with cash on hand and debt. Johnson & Johnson is also expected ...

Johnson & Johnson will acquire Intra-Cellular for $132 per share in cash, a 39 percent premium over Intra-Cellular's Friday closing price of $94.87. Following the announcement, shares of both ...

Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...

Johnson & Johnson JNJ4.13%increase; green up pointing triangle agreed to acquire mental-illness drug developer Intra-Cellular Therapies ITCI-0.11%decrease; red down pointing triangle for about $15 ...